• Gio. Nov 21st, 2024

trial

  • Home
  • BRCA, JOLIE E BALTI? NON C’E’ REGOLA CHE VALE PER TUTTE

BRCA, JOLIE E BALTI? NON C’E’ REGOLA CHE VALE PER TUTTE

La storia medica del Brca (la mutazione Jolie) non è solo medica. A voler raccontare bene delle donne che scoprono di avere una mutazione patogenetica che espone al rischio di…

‘Digital twins’ of real cancer patients with algorithms to discover black holes

Researchers have shown that they can accurately re-create clinical trials of new treatments using ‘digital twins’ of real cancer patients. The technology, called FarrSight®-Twin, which is based on algorithms used…

An AI-powered pipeline for personalized cancer vaccines

Ludwig Cancer Research scientists have developed a full, start-to-finish computational pipeline that integrates multiple molecular and genetic analyses of tumors and the specific molecular targets of T cells and harnesses…

UNA NUOVA ERA PER L’ ONCOEMATOLOGIA PEDIATRICA. CONGRESSO NAZIONALE AIEOP

Da lunedì prossimo, 30 settembre, a mercoledì 2 ottobre l’Hotel Savoia Regency di Bologna diventa il palcoscenico del XLIX Congresso Nazionale di AIEOP (Associazione Italiana Ematologia e Oncologia Pediatrica), un…

Evening vs. morning dosing of blood pressure medication: no differences seen #ESCCongress #ESC24 #ESC2024

In two trials, one in frail elderly patients, evening administration of blood pressure (BP)-lowering medications had no clinical benefits over morning administration, according to late-breaking research presented in a Hot…

The antiviral tecovirimat is safe but did not improve Clade I #mpox resolution in Democratic Republic of the Congo DRC

The antiviral drug tecovirimat did not reduce the duration of mpox lesions among children and adults with clade I mpox in the Democratic Republic of the Congo (DRC), based on…

Immunotherapy approach shows potential in some people with metastatic solid tumors

Early findings from a small clinical trial provide evidence that a new cellular immunotherapy approach may be effective in treating metastatic solid tumors. In the trial, researchers from the National…

TUMORE DEL SENO: EVITARE IL BISTURI È POSSIBILE

Un’alta percentuale di pazienti con tumore al seno iniziale può evitare la chirurgia e ottenere lo stesso risultato oncologico grazie al trattamento percutaneo della crioablazione. È la conclusione attesa del…

Estrogen-Only Hormone Therapy may increase cancer risk while Estrogen-Progestin Combination may lower risk #ASCO24

For people who have been through menopause and have taken menopausal hormone therapy, conjugated equine estrogen (CEE) taken alone may increase the risk of developing and dying from ovarian cancer,…

NIH opens long COVID trials to evaluate treatments for autonomic nervous system dysfunction

Two phase 2 clinical trials to test the safety and effectiveness of three treatments for adults with autonomic nervous system dysfunction from long COVID have begun. The autonomic nervous system…